A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study.
A clinical trial evaluating the safety and efficacy of the CB1R inverse antagonist taranabant in overweight and obese patients: low-dose study.